MedPath
NMPA Approval

Doxofylline Injection

国药准字H20253668

March 18, 2025

Drug Information

多索茶碱注射液

注射剂

10ml:0.1g

化学药品

March 18, 2025

Company Information

Applicant Company

武汉市东湖开发区高新大道858号生物医药园A7展示中心

Manufacturing Company

湖北省安陆市碧涢路137号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多索茶碱注射液 - NMPA 批准文号 | MedPath